Xbrane Biopharma Participates in Upcoming Investor Conferences

English

News

PR

Xbrane Biopharma AB (Nasdaq Stockholm First North: XBRANE) announced today that Martin Åmark, Chief Executive Officer, will participate and host one-on-one investor meetings at the following upcoming investor conferences: 20th Annual Bio€quity Europe Conference and Jefferies 2019 Healthcare Conference.

Event Details:

20th Annual Bio€quity Europe Conference in Barcelona, Spain
Tuesday, May 21, 2019
Presentation at 11:00 a.m. CEST

Jefferies 2019 Healthcare Conference in New York, NY
Tuesday, June 4th – Friday June 7th, 2019

Contacts

Martin Åmark, CEO/IR
M: +46 (0) 763-093 777
E: martin.amark@xbrane.com

Susanna Helgesen, CFO
M: +46 (0) 708-278 636
E: susanna.helgesen@xbrane.com

About Us

Xbrane is a commercial phase Swedish biopharmaceutical company specialized in biosimilars. Xbrane has a patented protein production platform for development of biosimilars and world leading expertise in biosimilars. Xbrane’s headquarter is located in Solna outside of Stockholm and the company’s in-house research and development facilities are in Sweden and Italy. Xbrane is listed at Nasdaq First North since February 3rd, 2016 under the name XBRANE and Avanza Bank AB is Xbrane’s certified adviser (corp@avanza.se, +46 (0)8 409 421 20).
For more information see www.xbrane.com.

Attachments

Xbrane Biopharma Participates in Upcoming Investor Conferences